SCHEMBL4479666

SCHEMBL4479666

CC(=O)OC(C(=O)Nc1n[nH]c2cc(-c3ccc(N(C)C)cc3)ccc12)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 9/20 0.58
GSK3A P49840 1/20 0.49
FLT3 P36888 2/20 0.49
FGFR1 P11362 2/20 0.48
FGFR2 P21802 2/20 0.48
FGFR3 P22607 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
AAK1 Q2M2I8 2/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
ABL1 P00519 2/20 0.45
BCR P11274 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4491583 0.88 GSK3B (0.53) GSK3BGSK3AFGFR1FGFR2FGFR3
SCHEMBL4493437 0.88 HDAC6 (0.54) GSK3BGSK3AFGFR1FGFR2FGFR3
SCHEMBL4491415 0.87 GSK3B (0.64) GSK3BGSK3AFLT3FGFR1FGFR2
SCHEMBL4503236 0.86 GSK3B (0.50) GSK3BGSK3AFGFR1FGFR2FGFR3
SCHEMBL4502553 0.86 HDAC6 (0.55) GSK3BGSK3AFGFR1FGFR2FGFR3
SCHEMBL4480211 0.86 GSK3B (0.58) GSK3BGSK3AFGFR1FGFR2FGFR3
SCHEMBL4496026 0.85 GSK3B (0.49) GSK3BGSK3AFGFR1FGFR2FGFR3
SCHEMBL4476038 0.85 GSK3B (0.52) GSK3BGSK3AFGFR1FGFR2FGFR3
SCHEMBL4493566 0.85 HDAC6 (0.54) GSK3BGSK3AFGFR1FGFR2FGFR3
SCHEMBL4478167 0.85 FGFR2 (0.55) GSK3BGSK3AFGFR1FGFR2FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632854-B2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2009-12-15 US claimed